Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes.

Schloemer NJ, Brickler M, Hoffmann R, Pan A, Simpson P, McFadden V, Block J, Tower RL 2nd, Burke MJ.

J Pediatr Hematol Oncol. 2017 Jul;39(5):e254-e258. doi: 10.1097/MPH.0000000000000838.

PMID:
28452856
2.

Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.

Marina NM, Liu Q, Donaldson SS, Sklar CA, Armstrong GT, Oeffinger KC, Leisenring WM, Ginsberg JP, Henderson TO, Neglia JP, Stovall MA, Yasui Y, Randall RL, Geller DS, Robison LL, Ness KK.

Cancer. 2017 Jul 1;123(13):2551-2560. doi: 10.1002/cncr.30627. Epub 2017 Feb 21.

PMID:
28222219
3.

Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.

Moudgil R, Yeh ET.

Can J Cardiol. 2016 Jul;32(7):863-870.e5. doi: 10.1016/j.cjca.2016.01.027. Epub 2016 Feb 2. Review.

4.

Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.

Lipshultz SE, Anderson LM, Miller TL, Gerschenson M, Stevenson KE, Neuberg DS, Franco VI, LiButti DE, Silverman LB, Vrooman LM, Sallan SE; Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.

Cancer. 2016 Mar 15;122(6):946-53. doi: 10.1002/cncr.29872. Epub 2016 Jan 13.

5.

Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program.

Barlogis V, Auquier P, Bertrand Y, Chastagner P, Plantaz D, Poiree M, Kanold J, Berbis J, Oudin C, Vercasson C, Allouche M, Tabone MD, Thouvenin-Doulet S, Saumet L, Chambost H, Baruchel A, Leverger G, Michel G.

Haematologica. 2015 May;100(5):e186-9. doi: 10.3324/haematol.2014.116574. Epub 2015 Jan 23. No abstract available.

6.

Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review.

Hefti E, Blanco JG.

Cardiovasc Toxicol. 2016 Jan;16(1):5-13. doi: 10.1007/s12012-015-9307-1. Review.

7.

Cardiovascular disease in adult survivors of childhood cancer.

Lipshultz SE, Franco VI, Miller TL, Colan SD, Sallan SE.

Annu Rev Med. 2015;66:161-76. doi: 10.1146/annurev-med-070213-054849. Review.

8.

Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia.

Karakaya P, Yılmaz S, Tüfekçi O, Kır M, Böber E, Irken G, Oren H.

Turk J Haematol. 2013 Sep;30(3):290-9. doi: 10.4274/Tjh.2012.0094. Epub 2013 Sep 5.

9.

Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes.

Lipshultz SE, Miller TL, Lipsitz SR, Neuberg DS, Dahlberg SE, Colan SD, Silverman LB, Henkel JM, Franco VI, Cushman LL, Asselin BL, Clavell LA, Athale U, Michon B, Laverdière C, Schorin MA, Larsen E, Usmani N, Sallan SE; Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.

Pediatrics. 2012 Dec;130(6):1003-11. doi: 10.1542/peds.2012-0727. Epub 2012 Nov 19.

10.

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.

Harake D, Franco VI, Henkel JM, Miller TL, Lipshultz SE.

Future Cardiol. 2012 Jul;8(4):647-70. doi: 10.2217/fca.12.44. Review.

11.

Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.

Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, Silverman LB, Colan SD, Neuberg DS, Dahlberg SE, Henkel JM, Asselin BL, Athale UH, Clavell LA, Laverdière C, Michon B, Schorin MA, Sallan SE.

J Clin Oncol. 2012 Apr 1;30(10):1042-9. doi: 10.1200/JCO.2010.30.3404. Epub 2012 Feb 27.

12.

Review of cardiotoxicity in pediatric cancer patients: during and after therapy.

Fulbright JM.

Cardiol Res Pract. 2011;2011:942090. doi: 10.4061/2011/942090. Epub 2011 May 23.

13.

Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.

Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B.

J Cancer Surviv. 2012 Mar;6(1):95-101. doi: 10.1007/s11764-011-0186-6. Epub 2011 Jun 1.

14.

Cardiovascular effects in childhood cancer survivors treated with anthracyclines.

Franco VI, Henkel JM, Miller TL, Lipshultz SE.

Cardiol Res Pract. 2011 Feb 10;2011:134679. doi: 10.4061/2011/134679.

15.

Cardiac function in long-term survivors of childhood lymphoma.

Friedberg MK, Solt I, Weyl-Ben-Arush M, Braver Y, Lorber A.

Cardiol Res Pract. 2011 Jan 20;2011:316927. doi: 10.4061/2011/316927.

16.

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.

Lipshultz SE, Scully RE, Lipsitz SR, Sallan SE, Silverman LB, Miller TL, Barry EV, Asselin BL, Athale U, Clavell LA, Larsen E, Moghrabi A, Samson Y, Michon B, Schorin MA, Cohen HJ, Neuberg DS, Orav EJ, Colan SD.

Lancet Oncol. 2010 Oct;11(10):950-61. doi: 10.1016/S1470-2045(10)70204-7. Epub 2010 Sep 16.

17.

Dexrazoxane for preventing anthracycline cardiotoxicity in children with solid tumors.

Choi HS, Park ES, Kang HJ, Shin HY, Noh CI, Yun YS, Ahn HS, Choi JY.

J Korean Med Sci. 2010 Sep;25(9):1336-42. doi: 10.3346/jkms.2010.25.9.1336. Epub 2010 Aug 12.

18.

Cardiac functional evaluation using vector velocity imaging after chemotherapy including anthracyclines in children with cancer.

Park JH, Kim YH, Hyun MC, Kim HS.

Korean Circ J. 2009 Sep;39(9):352-8. doi: 10.4070/kcj.2009.39.9.352. Epub 2009 Sep 30.

19.

Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity.

Lee HS, Son CB, Shin SH, Kim YS.

Cancer Res Treat. 2008 Sep;40(3):121-6. doi: 10.4143/crt.2008.40.3.121. Epub 2008 Sep 30.

20.

Anthracycline cardiotoxicity: from bench to bedside.

Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB.

J Clin Oncol. 2008 Aug 1;26(22):3777-84. doi: 10.1200/JCO.2007.14.9401.

Supplemental Content

Support Center